Skip to main content

Drug Interactions between Aliqopa and M-M-R II

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Major

measles virus vaccine copanlisib

Applies to: M-M-R II (measles virus vaccine / mumps virus vaccine / rubella virus vaccine) and Aliqopa (copanlisib)

If you are currently being treated or have recently been treated with copanlisib, you should let your doctor know before receiving measles virus vaccine. Depending on the dose and length of time you have been on copanlisib, you may be at risk for developing an infection from the vaccine or have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of copanlisib therapy. Conversely, if you have recently been vaccinated with measles virus vaccine, your doctor may choose to postpone treatment with copanlisib for a few weeks. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Major

rubella virus vaccine copanlisib

Applies to: M-M-R II (measles virus vaccine / mumps virus vaccine / rubella virus vaccine) and Aliqopa (copanlisib)

If you are currently being treated or have recently been treated with copanlisib, you should let your doctor know before receiving rubella virus vaccine. Depending on the dose and length of time you have been on copanlisib, you may be at risk for developing an infection from the vaccine or have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of copanlisib therapy. Conversely, if you have recently been vaccinated with rubella virus vaccine, your doctor may choose to postpone treatment with copanlisib for a few weeks. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Major

mumps virus vaccine copanlisib

Applies to: M-M-R II (measles virus vaccine / mumps virus vaccine / rubella virus vaccine) and Aliqopa (copanlisib)

If you are currently being treated or have recently been treated with copanlisib, you should let your doctor know before receiving mumps virus vaccine. Depending on the dose and length of time you have been on copanlisib, you may be at risk for developing an infection from the vaccine or have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of copanlisib therapy. Conversely, if you have recently been vaccinated with mumps virus vaccine, your doctor may choose to postpone treatment with copanlisib for a few weeks. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

Moderate

copanlisib food

Applies to: Aliqopa (copanlisib)

Grapefruit juice can increase the blood levels of copanlisib. This may increase side effects such as nausea, vomiting, diarrhea, mouth sores, high blood sugar, high blood pressure, lung or breathing problems, severe skin reactions, and impaired bone marrow function resulting in low numbers of different types of blood cells. You may also be more likely to develop anemia, bleeding problems, or infections due to low blood cell counts. You should avoid the consumption of grapefruit and grapefruit juice during treatment with copanlisib. Talk to your doctor or pharmacist if you have questions on this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.